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Adult male Wistar rats were enrolled in a study to test the acute hepatic ef-
fects of 50 mg/kg fumonisin B1 in feed for 5 days. Fumonisin B1 depressed growth 
and feed intake, and absolute and relative liver weight showed a significant in-
crease. The proportions of C17:0, C18:3 n3, C22:5 n3 and C22:6 n3 fatty acids 
decreased in the hepatic phospholipid fraction. All proportional decreases modified 
the hepatocellular membrane lipids into a more rigid state. The fatty acid profile 
modifications were partly compensated for by endogenous glutathione (prevent-
ing the formation of conjugated dienes and trienes as initial phase lipid peroxida-
tion indicators), while the enzymatic antioxidant defence system (glutathione per-
oxidase) was unaltered. In contrast, hepatic malondialdehyde, the cytotoxic product 
of end-phase lipid peroxidation showed a concentration increase even after 5 days 
of feeding. The results indicate a rather strong and rapid hepatic effect of FB1, 
immediately impairing membrane phospholipids, even before the enzymatic anti-
oxidant defence is activated.  
Key words: Fumonisin B1, rat, hepatocellular membrane, fatty acids, oxi-
dative stress, antioxidants 
Fumonisins are cancer-inducing metabolites of Fusarium proliferatum and 
Fusarium verticillioides. They have a long-chain hydrocarbon unit (mimicking to 
a certain extent cellular sphingosine and sphinganine), which plays a determinant 
role in their cell-membrane-associated toxicity. From the fumonisin group, fu-
monisin B1 (FB1) shows strong toxic effects and has been reported to promote 
hepatic tumour in rats. Fumonisin B1, the most abundant of the numerous fu-
monisin analogues, was classified by the IARC as a Group 2B carcinogen (pos-
sibly carcinogenic in humans; IARC, 2002). 
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Focusing merely on the hepatic effects of FB1, Gelderblom et al. (2001) 
reported that in rat liver FB1 initiates cancer primarily by exerting hepatotoxic ef-
fects and through augmented lipid peroxidation. In an earlier study Abel and 
Gelderblom (1998) reported significantly increased thiobarbituric acid reactive 
substance (TBARS) level as a result of 250 and 500 mg/kg FB1 exposure in the 
feed for 21 days, causing damage to cellular and microsomal membranes as well. 
Perhaps this was the first hint that FB1 sensitises hepatocytes toward oxidative 
stress. As a consequence, emerging free radicals induce hepatocellular damage 
and metabolic abnormalities. Based on the above information, Abel and Gelder-
blom (1998) classified FB1 as a hepatotoxic but non-genotoxic compound in rats. 
Sahu et al. (1998) studied whether FB1 affects nuclear membranes and DNA in 
the rat liver, and confirmed the induction of nucleolemmal lipid peroxidation as 
well as DNA strand breaks. Interestingly, for the compensation of lipid peroxida-
tion only catalase was found to provide an antioxidant activity increase. Sahu et 
al. (1998) hypothesised that peroxyl radicals and hydroxyl radicals are responsi-
ble for the DNA damage. 
Lipid-compositional changes underlying microscopic alterations caused by 
FB1 were partly elucidated by Gelderblom et al. (1997) by feeding rats a drasti-
cally toxic, cancer-promoting level (250 mg/kg feed) of this toxin. They found 
altered lipid constituent proportions; in particular phosphatidylethanolamines 
(PE) were significantly increased in the mitochondrial and even in the plasma 
membrane fractions. In a recent study on the effects of a 10 mg/kg FB1 supple-
mentation in the feed of rats for 28 days we confirmed these changes in the fatty 
acid (FA) composition of the hepatic mitochondrial phospholipids (PL) (Szabó et 
al., 2016). In the FA profile of the main polar lipid fractions, i.e. phosphatidyl-
choline (PC) and PE, a decreased arachidonic acid (C20:4 n6) and polyunsatu-
rated/saturated FA ratio was demonstrated, suggesting a less fluid membrane 
structure. The decreased levels of polyunsaturated fatty acids (PUFA) in PC along 
with a marked elevation of oleic (C18:1 n9) and linoleic (C18:2 n6) acids were 
indicative of an impaired Δ6 desaturase activity. The authors concluded that FB1 
disrupts sphingolipid, phospholipid (the effect of a polar toxin molecule on the 
cellular polar lipid fractions), cholesterol and FA metabolism in the liver, in a 
manner decreasing membrane fluidity and ultimately leading to apoptosis. It has 
to be added that all the above-listed cellular-level reactions were attained with 
the lowest FB1 dose of 10 and 50 mg/kg fed for a minimum period of 21 days. 
As far as the authors are aware, the acute effects of FB1 have only been 
tested in vitro (24–48 h; Abel and Gelderblom, 1998). Since those settings are 
hardly comparable with an in vivo trial, we aimed to test the acute effects of a 
relatively low but realistic dose of FB1 (50 mg/kg feed) using an exposure that 
lasted for only 5 days. The study included the partial analysis of the initial, 
propagation and end-phases of lipid peroxidation and the determination of some 
endogenous antioxidants in rats. 
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Materials and methods 
Animals and feeding 
Adult, male Wistar Crl:WI BR rats (8 weeks of age) were enrolled in the 
study and were kept in metabolic cages (Tecniplast, Castronno, Italy) individu-
ally. The animals (n = 6/group, FB1 vs. control, total n = 12) were fed Ssniff 
R/M-Z+H feed (Ssniff GmbH, Soest, Germany; Table 1). The Ssniff basic feed 
was ground on a 0.75-mm sieve size Retsch SR200 (Retsch GmbH, Haan, Ger-
many) feed mill, and water and – only for the formula with added FB1 – my-
cotoxin-containing fungal culture were added (the protocol is described below).  
Table 1 
Chemical and fatty acid composition of the diet 
Chemical composition  
Dry matter (%) 88.4 
Crude protein (%) 19 
Crude fat (%) 3.5 
Crude fibre (%) 3.6 
Crude ash (%) 6.5 
N-free extract (%) 55.9 
Gross energy (MJ/kg) 16.4 
Metabolisable energy (MJ/kg) 13.4 
Fatty acid composition Weight % 
C14:0 0.01 
C16:0 0.49 
C16:1 n7 0.01 
C18:0 0.08 
C18:1 n9 0.65 
C18:2 n6 1.9 
C18:3 n3 0.25 
C20:0 0.01 
C20:1 n9 0.02 
 
The mixture was homogenised, re-granulated and dried at 40 °C. The same 
preparation protocol was applied for the control animals but no fungal culture 
was mixed into their feed. The rats were kept in a 12-hour light and 12-hour dark 
daily rhythm, at 20 °C in a rodent room. The relative air humidity was 50%. Feed 
was offered ad libitum, and feed intake was measured daily. Water was offered 
ad libitum, and body weight was measured at the start and end of the study. After 
five days of feeding the experimental and control diets respectively, the rats were 
sacrificed by cervical dislocation and were immediately dissected. Total dis-
sected fresh livers were weighed immediately and 0.5 g of the right lobe was 
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stored frozen (–80 °C) in Eppendorf tubes until analysis. Absolute weight was 
the fresh total liver weight; relative weight means the liver weight as a percent-
age of the total body mass. The kidney weight was also determined freshly. The 
experimental protocol was authorised by the Food Chain Safety and Animal 
Health Directorate of the Somogy County Agricultural Office, under the allow-
ance number SOI/31/1679-11/2014. 
Mycotoxin production 
Fumonisin B1 was produced by the application of Fusarium verticillioides 
strain MRC 826 according to the method of Fodor et al. (2008). The homoge-
nised fungal culture contained FB1 at a concentration of 3.44 g/kg. This fungal 
culture was mixed into the basal diet of the experimental animals, so as to pro-
vide feed contaminated with 50 mg/kg FB1 toxin. 
The mycotoxin concentration of the control and the experimental diet was 
determined by LC-MS (Shimadzu, Kyoto, Japan). The lower limit of detection 
(LOD) for FB1 was 3 µg/kg. The diet fed to the control group did not contain de-
tectable amounts of FB1 (the complete absence of deoxynivalenol, zearalenone 
and T-2 toxin was as well controlled and confirmed). 
Lipid analysis 
Liver samples and the feed were homogenised (IKA T25 Digital Ultra 
Turrax, Staufen, Germany) in 20-fold volume of chloroform:methanol (2:1 v:v) 
and total lipid content was extracted according to Folch et al. (1957). Solvents 
were ultrapure-grade (Sigma-Aldrich, Schnelldorf, Germany) and 0.01% w:v bu-
tylated hydroxytoluene was added to prevent fatty acid oxidation. For the separa-
tion of lipid fractions, extracted total lipids were transferred to glass chroma-
tographic columns, containing 300 mg silica gel (230–400 mesh) for 10 mg of 
total lipids (Leray et al., 1997). Neutral lipids were eluted with 10 mL chloroform 
for the above fat amount, then 15 mL acetone:methanol (9:1 v:v) was added, 
while 10 mL pure methanol eluted the total phospholipids. This latter fraction 
was evaporated under a nitrogen stream and was transmethylated with a base-
catalysed NaOCH3 method (Christie, 1982). Fatty acid methyl esters were ex-
tracted into 300 μL ultrapure n-hexane for gas chromatography, which was per-
formed on a Shimadzu 2010 apparatus (AOC 20i automatic injector), equipped 
with a Phenomenex Zebron ZB-WAX Capillary GC column (30 m × 0.25 mm ID, 
0.25 micrometer film, Phenomenex Inc., Torrance, CA, USA) and a flame ioni-
sation detector (FID 2 × 10–11). Characteristic operating conditions were: injector 
temperature: 270 °C, detector temperature: 300 °C, helium flow: 28 cm/sec. The 
oven temperature was graded: from 80 to 205 °C: 2.5 °C/min, 5 min at 205 °C, 
from 205 to 250 °C 10 °C/min and 5 min at 210 °C. The makeup gas was nitro-
gen. To identify individual FA, an authentic external FA standard (37 Compo-
440 SZABÓ et al. 
Acta Veterinaria Hungarica 64, 2016 
nent FAME Mix, Sigma-Aldrich, Cat. No.: CRM47885) was used. Fatty acid re-
sults were expressed as weight % of total fatty acid methyl esters. 
Analysis of lipid peroxidation 
Lipid peroxidation (end-phase) was assessed by the determination of 
malondialdehyde (MDA) levels using the 2-thiobarbituric acid method (Placer et 
al., 1966). The concentration of reduced glutathione (GSH) was measured by 
photometry (Sedlak and Lindsay, 1968) and the activity of glutathione peroxi-
dase (GPx) was determined according to Lawrence and Burk (1978). The con-
centration of conjugated dienes and trienes (initial phase lipid peroxidation) was 
determined by spectrophotometry (absorbance: 232 and 268 nm, respectively), 
using AOAC (1984) methods. All analyses were performed from liver tissue 
samples after storage at –80 °C. 
Statistical analysis 
For the comparison of group means (body weight, liver weight, feed in-
take), independent samples t-test was used with the SPSS 20 software (2012). 
Oxidation products, antioxidant parameters and FAs were compared by univari-




Body weight, liver weight, feed intake 
At the beginning and at the end of the experiment the body weight was not 
different between the FB1-intoxicated and the control groups (Table 2). The con-
trol group showed a slight (not significant) body weight gain, while FB1 feeding 
compromised the growth of rats (the difference was not significant). When com-
paring the cumulative alterations during the five experimental days, significant 
difference was found in body weight gain between the FB1-fed and the control 
groups. The liver weight and the relative liver weight showed a significant in-
crease as a result of toxin feeding (FB1 > control at day 5). No difference was 
found between the groups in kidney weight. 
Feed intake tended to be lower in the group fed the FB1-containing diet 
during the study, but the difference was significant only at days 3 and 4 (Fig. 1). 
Fatty acid composition of hepatic phospholipids 
Among the fatty acids determined (Table 3), the proportions of margaric 
acid (C17:0), α-linolenic acid (C18:3 n3), docosapentaenoic acid (C22:5 n3) and 
docosahexaenoic acid (C22:6 n3) were significantly higher than in the control 
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animals. This led to a significant decrease of the total n3 FA proportion and a 
concomitant increase of the n6/n3 ratio. Neither the number of double bonds in 
100 acyl chains (unsaturation index, UI) nor the average fatty acyl chain length 
(ACL) was affected by the mycotoxin exposure. 
Table 2 
Somatic traits of the control and the fumonisin B1-fed groups (n = 6 per group) 
Somatic traits Control group (mean ± SEM) 
Fumonisin B1 
(mean ± SEM) P (t-test) 
Initial body weight, g 210.4 ± 12.4 242.3 ± 10.0 NS 
Final body weight, g 217.3 ± 13.1 223.7 ± 23.0 NS 
Liver, g 6.16 ± 0.30 7.50 ± 0.74 0.004 
Kidneys, g 1.46 ± 0.15 1.67 ± 0.19 NS 
Relative liver weight, % 2.85 ± 0.29 3.83 ± 0.45 0.049 
Relative kidney weight, % 0.67 ± 0.10 0.75 ± 0.11 NS 
Body weight gain, g 6.92 ± 2.55 –18.6 ± 24.8 0.05 
NS = not significant 
 
Fig. 1. Feed intake of the animals during the trial (g/day/animal) 
Antioxidants and lipid peroxidation  
Comparing the control and the FB1-fed groups (Table 4) at the end of the 
study (day 5), the hepatic GSH concentration was lower and the tissue MDA 
concentration was higher in the FB1-fed group, while the activity of GPx was not 
different. In contrast, FB1-exposure significantly decreased the hepatic tissue 
concentration of conjugated dienes and conjugated trienes as compared to the 
control at the end of the experiment. 
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P = 0.05 
P = 0.04 
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Table 3 
Alterations caused by fumonisin B1 feeding in the fatty acid composition of hepatic total  
phospholipids 
Fatty acid composition of 
hepatic phospholipids 
Control group 
(mean ± SEM) 
Group fed fumonisin B1
(mean ± SEM) 
Difference P  
(ANOVA) 
C14:0 0.21 ± 0.02 0.22 ± 0.09 NS 
C15:0 0.21 ± 0.04 0.17 ± 0.06 NS 
C16:0 16.3 ± 7.60 19.6 ± 3.68 NS 
C16:1 n7 1.09 ± 0.15 0.97 ± 0.47 NS 
C17:0 0.53 ± 0.10 0.41 ± 0.02 0.017 
C18:0 19.1 ± 1.58 19.6 ± 2.85 NS 
C18:1 n9 5.40 ± 0.76 4.39 ± 0.76 NS 
C18:2 n6 14.2 ± 2.18 14.00 ± 1.55 NS 
C18:3 n3 0.12 ± 0.01 0.10 ± 0.01 0.038 
C20:1 n9 0.10 ± 0.03 0.10 ± 0.02 NS 
C20:2 n6 0.53 ± 0.07 0.32 ± 0.20 NS 
C20:3 n6 1.25 ± 0.15 0.91 ± 0.35 NS 
C20:4 n6 31.4 ± 2.49 31.8 ± 1.84 NS 
C22:5 n3 1.09 ± 0.20 0.75 ± 0.23 0.032 
C22:6 n3 8.33 ± 0.75 6.67 ± 1.19 0.025 
Σ saturated 36.5 ± 6.10 40.1 ± 1.70 NS 
Σ unsaturated 63.5 ± 6.07 59.9 ± 1.74 NS 
Σ monoenoic 6.56 ± 0.81 5.41 ± 1.20 NS 
Σ polyenoic 57.0 ± 5.38 54.5 ± 2.17 NS 
Σ n3 9.54 ± 0.92 7.52 ± 1.33 0.019 
Σ n6 47.4 ± 4.72 47.0 ± 1.09 NS 
Σ n6 / Σ n3 4.99 ± 0.40 6.43 ± 1.28 0.039 
UI 220.8 ± 19.2 207.4 ± 12.8 NS 
ACL 18.66 ± 0.23 18.52 ± 0.17 NS 
NS = not significant; UI = unsaturation index; ACL = average fatty acyl chain length 
 
Table 4 
Hepatic antioxidant and oxidation parameters of the control and the toxin-fed rats 
Hepatic antioxidant parameters Control group (mean ± SEM) 
Group fed fumonisin B1
(mean ± SEM) 
Difference* 
P (ANOVA) 
GSH (micromoles/g protein) 3.90 ± 0.26  3.76 ± 0.12 0.045 
GPX (IU/g protein) 2.97 ± 0.32 2.87 ± 0.09  NS 
MDA (micromoles/g) 15.4 ± 1.66 18.71 ± 1.37 0.06 
Conjugated dienes (ABS 232 nm) 0.25 ± 0.005  0.22 ± 0.004  0.007 
Conjugated trienes (ABS 268 nm) 0.12 ± 0.003 0.11 ± 0.002 0.008 
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Discussion 
Body weight, liver weight, feed intake 
The first notable hint that FB1 depresses growth in rats was published by 
Gelderblom et al. (1994), who applied a longer (21-day) setting with the lowest 
FB1 concentration of 250 mg/kg feed. According to these authors, feed refusal is 
provoked by FB1 within the first 14 feeding days and this effect is diminished 
later on (in the last 7 days). 
Concerning liver weight, Gelderblom et al. (1994) reported that FB1 effec-
tively delays hepatocyte proliferation in two feeding regimes: 250 mg FB1/kg feed 
for 21 days and even by a single gavage dose of 5 mg FB1/100 g body weight. In 
contrast, Abel and Gelderblom (1998) showed that FB1 contaminations at doses 
of 10, 50 and 100 mg/kg feed for 21 days, respectively, did not adversely affect 
the body weight gain and the relative liver weight; this effect was only found at 
doses of 250 and 500 mg/kg feed. 
Abel and Gelderblom (1998) found a lowered feed intake only at an FB1 
concentration of 250 mg/kg feed, and in the 21-day study the feed intake reached 
the control level after 14 days. It is thus a new finding of the present study that 
even an FB1 dose of 50 mg/kg feed has an adverse effect on the feed intake, and 
this occurs as early as three days after toxin administration. 
Fatty acid composition of hepatic phospholipids 
The FA composition analysis of hepatic total phospholipids was invented 
to provide novel data on the acute membrane-damaging effect of FB1. The pres-
ence of margaric acid (C17:0) is bound to microbial activity, since vertebrates do 
not synthesise odd-chain FAs (Leray, 2013). As rats perform coprophagy, they 
ingest bacterial fatty acids which are then incorporated into their glycerolipids. It 
is important to note that in rabbits (performing caecotrophy) the red cell mem-
brane (Szabó et al., 2014) and the hepatic mitochondrial membrane (Szabó et al., 
2016) showed identical changes as a result of 10 mg/kg feed FB1 exposure for 28 
days. It might be thus assumed that in rodents the lowered cell membrane marga-
ric acid proportion (induced by FB1 toxin exposure) contributed to the increase 
of membrane fluidity, as a means of counterbalancing the proportional decrease 
of the much more fluid polyunsaturated FAs (C22 PUFAs). 
The decrease of the C22 penta- and hexaenoic acids was preceded by a 
slight proportional decrease of their precursor, α-linolenic acid. Although α-
linolenic acid was present in the diets as a minor component, its elongated and 
poly-desaturated products were not, as the Ssniff diet brand used in the study 
does not contain any animal by-products or traces thereof (Table 1). The reason 
why C22 n3 PUFA underwent a proportional decrease might be partly their very 
high sensitivity towards lipid peroxidation (as reflected by MDA and in particu-
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lar by GSH). The relative susceptibility difference between C18:3 n3 and C22:6 
n3 is approximately 4-fold (Hulbert, 2005). It may thus be a direct consequence 
of oxidative stress and membrane lipid damage that the peroxidation products of 
lipids (MDA) were indeed detected in the whole-tissue samples (Table 4). 
Gelderblom et al. (1997) reported detailed results on FB1-induced alterations of 
non-ceramide, polar lipids in the rat liver. The trial settings were different from 
ours, namely 1–10–20 mg/kg feed for two years and 50–100–250 mg/kg feed for 
21 days, respectively. In those trials the FA profile of the PC and PE fractions 
was determined, while in our analysis these were not handled separately. Any-
how, the alterations detected were of similar nature. Gelderblom et al. (1997) re-
ported a characteristic n6 (C18:2 n6) FA proportional increase in the PE fraction 
at FB1 doses of 100 and 250 mg/kg feed. Lower toxin concentration but pro-
longed exposure induced identical alterations in the total FAs of the liver. Ac-
cording to Gelderblom et al. (1997), there is a shift within the n6 FA group (↑ 
C18:2 n6 and ↓C22:5 n6), not via the reduction of the n3 FAs, but due to the dis-
turbance of the Δ6 desaturase activity. Our study demonstrated the same phe-
nomenon, since Δ6 desaturation is an essential step (besides elongation and Δ5 
desaturation) in the metabolism (formation) of C22 PUFA in both groups. The 
authors furthermore reported decreased C20:4 n6 (arachidonic acid) levels in the 
plasma in both studies, though the formation of eicosanoids was not analysed. It is 
important that the disruption of PUFA (mostly n6) was attained at the 250 mg/kg 
feed dosage, while the lower dose applied in our trial led to a similar effect in the 
n3 FA group of profound oxidative sensitivity. Gelderblom et al. (1997) defined 
this effect as a part of the acute effect of FB1; in the longer-term treatment this 
oxidative effect was not proved and, in addition, the n3 FA proportion increased 
in the PE and PC fractions. The authors draw the conclusion that the potentially 
emerging eicosanoids might have been the compounds that retarded cell growth 
(lower relative liver weight). Not rejecting this hypothesis, the present dataset 
adds confirmative information that the hepatocellular antioxidant defence system 
may also play a compensatory role against entering the propagation phase of 
lipid peroxidation. This is supported by the production of conjugated dienes and 
conjugated trienes, which are formed mostly during the initiation phase of lipid 
peroxidation (Halliwell and Cross, 1994). 
Reduced glutathione and glutathione peroxidase 
Reduced glutathione is a well-known marker of cell antioxidative capacity 
used in toxicological studies as well (Klaric et al., 2007). Hepatic GSH level was 
slightly lowered by FB1 in our study. Numerous published studies confirm that 
FB1 exposure effectively lowers plasma or whole liver GSH concentration, but 
one of the most targeted studies pointed out that this decrease is ultimately the 
result of oxidative stress associated free radical scavenging (Stockmann-Juvala et 
al., 2004). According to the authors, FB1 may act as a cell membrane structure 
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modifying compound, altering the membrane lipid profile (see the section Fatty 
acid composition of hepatic phospholipids) and thus contributing to hydrogen 
peroxide production. Although FB1 is primarily a ceramide synthesis inhibitor 
(Dutton, 1996), it is well known that, as a secondary effect, FB1 effectively 
modifies hepatic PL composition in rats (Gelderblom et al., 1997). The fatty acid 
profile of the lipid fractions analysed was enriched in n6 FAs in the long-term 
study, showing a compensatory effect against augmented lipid oxidation. 
Glutathione functions as an electron donor; it is easily reduced, which 
form is then rapidly converted to glutathione disulphide by glutathione reductase. 
In our study the activity of this enzyme was not determined, but that of another 
antioxidant enzyme, glutathione peroxidase (GPx) was. According to Kang and 
Alexander (1996), kidney cells do not react to FB1 with a GPx activity alteration 
in vitro, but Marnewick et al. (2009) reported increased GPx activity induced by 
an FB1 dose of 250 mg/kg feed for 21 days in rats. Our short and not drastically 
high exposure did not affect the hepatic tissue activity of GPx. 
Based on the above information it seems that a short-time and relatively 
low-dose FB1 exposure does not evoke enzymatic antioxidant defence (GPx) but 
influences non-enzymatic (GSH) antioxidant activity, most probably via the 
augmented production of lipid-derived oxidation products (MDA). 
Conjugated dienes and conjugated trienes  
During the formation of hydroperoxides from PUFA, conjugated dienes 
(CD) and conjugated trienes (CT) are typically produced, due to the rearrange-
ment (virtually migration) of the double bonds, which are naturally allocated in a 
methylene-group interrupted form. The resulting CDs absorb at 234 nm, while 
CTs at 268 nm. Conjugated dienes are more stable than non-conjugated dienes 
due to factors such as delocalisation of charge through resonance and hybridisa-
tion energy (Mead et al., 1986). 
The finding that in our study CD and CT production was diminished by 
FB1 might be explained by two factors: (1) the proportion of their precursor FAs 
was lower in the FB1-intoxicated animals, and (2) in the hepatocellular plasma 
the concentration of endogenously synthesised antioxidants (primarily GSH) was 
rather high (5–10 mM), and these compounds were readily present to inhibit the 
propagation of lipid peroxidation. As far as the authors are aware, there are two 
reports characterising the augmented initiation phase of lipid peroxidation by 
means of CDs and CTs (Szabó-Fodor et al., 2015; Bócsai et al., 2016), but as an 
effect of T-2 and deoxynivalenol + zearalenone toxins, respectively. For fu-
monisin B1 this is the first report analysing the initial phase of lipid peroxidation, 
which was in fact effectively compensated for by the endogenous GSH and the 
relative substrate shortage. 
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Malondialdehyde 
Malondialdehyde is a product of methyl-fatty acids, formed via an inter-
mediate step as prostaglandin-like endoperoxide (Pryor and Stanley, 1975). It is 
produced from PUFA with at least two methylene-interrupted double bonds, and 
once emerging, it is present as a less reactive (but mostly towards DNA) enolate 
anion, exerting genotoxic effects. Malondialdehyde is known to crosslink and 
polymerise membrane components and to react with nitrogenated DNA bases to 
form common adducts (Abel and Gelderblom, 1998). Abel and Gelderblom (1998) 
reported in vitro results on primary rat hepatocytes, namely FB1-induced MDA 
production. Sahu et al. (1998) reported elevated MDA production in vitro as a 
result of FB1, originating from the nucleolemmal lipid peroxidation and aug-
menting DNA damage. However, Domijan et al. (2008) showed that low, single-
dose treatment with FB1 (5, 50 and 500 μg/kg body weight) did not induce oxida-
tive stress, while markedly damaged liver cell DNA was found. In our study a 
slight increase was found, meeting a less strict significance level. The reason for 
this might be that the production of MDA depends on its precursors (primarily 
n3 PUFA), most of which were decreased (Table 3) and have profound and spe-
cific oxidative sensitivity (Tirosh et al., 2015). However, MDA is not only cyto-
toxic but also indicative of the end-phase of lipid peroxidation and a pathological 
state (Del Rio et al., 2005). 
 
Conclusions 
Testing the acute effects of a naturally occurring fumonisin B1 dose (50 mg/ 
kg feed), in a rather short exposure period, decrease of mostly elongated, n3 
polyunsaturated fatty acids was found in the hepatic total phospholipids of rats. 
This fatty acid profile modification effect was partly compensated for by the en-
dogenous glutathione (preventing the production of conjugated dienes and trie-
nes, as initial phase of lipid peroxidation products), meanwhile enzymatic anti-
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